Zhongxin Finance, January 14th. On the 13th, International Medical issued an announcement stating that the company's subordinate Xi'an High-tech Hospital and Xi'an International Medical Center Hospital received the "Xi'an Municipal Health Commission on Xi'an High-tech Hospital and Xi'an International Medical Center Hospital" on January 13, 2022. Announcement on the Handling of the Medical Center Hospital", after research by the Xi'an Municipal Health Commission, the two hospitals have been closed for 3 months for rectification, and they will reopen after the rectification has passed.
The shares of International Medical Corporation will be suspended for one day from the opening of the market on January 14, 2022, and will resume trading from the opening of the market on January 17, 2022.
The company's stock has been subject to other risk warnings since the opening of the market on January 17, 2022. The company's stock abbreviation has been changed from "International Medicine" to "ST Chinese Medicine", the stock code is still "000516", and the stock trading day is limited to 5 %.
The announcement shows that after the current round of the epidemic in Xi'an, the company's high-tech hospitals and central hospitals mechanically implemented relevant epidemic prevention policies, delaying the rescue and diagnosis and treatment of critically ill patients, causing widespread public concern and serious consequences.
Regarding the occurrence of this incident, International Medicine said that it was extremely saddened, remorseful and remorseful, and expressed its deep apology to the patients, their families and the public, and would do their best to handle the postoperative recovery of the patients and their families. Treatment, appeasement, compensation and other work, in-depth reflection, immediate rectification, lessons learned, and accountability of relevant responsible persons.
(Finish)